 Todd Hankinson
Concepts (445)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniopharyngioma | 21 | 2025 | 82 | 7.530 |
Why?
| | Pituitary Neoplasms | 18 | 2025 | 184 | 5.640 |
Why?
| | Arnold-Chiari Malformation | 13 | 2025 | 32 | 3.580 |
Why?
| | Brain Neoplasms | 27 | 2025 | 1138 | 3.500 |
Why?
| | Neurosurgical Procedures | 14 | 2024 | 170 | 3.500 |
Why?
| | Hydrocephalus | 15 | 2024 | 104 | 3.240 |
Why?
| | Brain Stem Neoplasms | 5 | 2016 | 89 | 1.860 |
Why?
| | Atlanto-Axial Joint | 7 | 2020 | 12 | 1.680 |
Why?
| | Magnetic Resonance Imaging | 21 | 2023 | 3357 | 1.660 |
Why?
| | Joint Instability | 7 | 2020 | 181 | 1.610 |
Why?
| | Ganglioglioma | 4 | 2016 | 31 | 1.580 |
Why?
| | Child | 86 | 2025 | 20860 | 1.580 |
Why?
| | Decompression, Surgical | 9 | 2024 | 97 | 1.540 |
Why?
| | Spinal Injuries | 4 | 2022 | 52 | 1.470 |
Why?
| | Ependymoma | 10 | 2024 | 175 | 1.430 |
Why?
| | Spinal Fusion | 9 | 2024 | 223 | 1.390 |
Why?
| | Ventriculoperitoneal Shunt | 9 | 2024 | 37 | 1.350 |
Why?
| | Glioma | 5 | 2021 | 348 | 1.300 |
Why?
| | Infratentorial Neoplasms | 7 | 2024 | 59 | 1.220 |
Why?
| | Pons | 4 | 2016 | 30 | 1.200 |
Why?
| | Occipital Bone | 5 | 2024 | 19 | 1.170 |
Why?
| | Child, Preschool | 42 | 2025 | 10462 | 1.150 |
Why?
| | Cervical Atlas | 3 | 2024 | 5 | 1.140 |
Why?
| | Sella Turcica | 2 | 2017 | 16 | 1.120 |
Why?
| | Xanthomatosis | 2 | 2017 | 11 | 1.120 |
Why?
| | Cervical Vertebrae | 9 | 2025 | 130 | 1.090 |
Why?
| | Dura Mater | 3 | 2021 | 31 | 1.080 |
Why?
| | Tomography, X-Ray Computed | 11 | 2022 | 2530 | 1.020 |
Why?
| | Syringomyelia | 5 | 2024 | 12 | 1.020 |
Why?
| | Cerebrospinal Fluid Shunts | 8 | 2024 | 32 | 0.970 |
Why?
| | Humans | 127 | 2025 | 129078 | 0.930 |
Why?
| | Machine Learning | 4 | 2025 | 418 | 0.890 |
Why?
| | Hematoma, Epidural, Spinal | 1 | 2023 | 2 | 0.870 |
Why?
| | Infant | 31 | 2024 | 8997 | 0.830 |
Why?
| | Cellular Senescence | 1 | 2024 | 176 | 0.810 |
Why?
| | Ventriculostomy | 7 | 2024 | 22 | 0.800 |
Why?
| | Neck Injuries | 1 | 2022 | 20 | 0.800 |
Why?
| | Neural Tube Defects | 4 | 2019 | 62 | 0.790 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2020 | 740 | 0.780 |
Why?
| | Adolescent | 44 | 2025 | 20241 | 0.760 |
Why?
| | Neurosurgery | 3 | 2013 | 34 | 0.760 |
Why?
| | SEER Program | 4 | 2018 | 208 | 0.740 |
Why?
| | Infant, Newborn | 15 | 2024 | 5707 | 0.710 |
Why?
| | Neuroendoscopy | 5 | 2024 | 20 | 0.710 |
Why?
| | Postoperative Complications | 12 | 2024 | 2497 | 0.700 |
Why?
| | Male | 64 | 2025 | 63248 | 0.690 |
Why?
| | Transcriptome | 7 | 2023 | 875 | 0.670 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2020 | 86 | 0.670 |
Why?
| | Down Syndrome | 2 | 2020 | 454 | 0.660 |
Why?
| | Female | 65 | 2025 | 68274 | 0.620 |
Why?
| | Neoplasm Recurrence, Local | 6 | 2024 | 952 | 0.600 |
Why?
| | Atlanto-Occipital Joint | 3 | 2024 | 5 | 0.600 |
Why?
| | Retrospective Studies | 31 | 2024 | 14562 | 0.590 |
Why?
| | Treatment Outcome | 27 | 2024 | 10256 | 0.580 |
Why?
| | Pituitary Diseases | 1 | 2017 | 21 | 0.560 |
Why?
| | Central Nervous System Neoplasms | 2 | 2019 | 147 | 0.560 |
Why?
| | Meningioma | 1 | 2018 | 77 | 0.550 |
Why?
| | Third Ventricle | 4 | 2024 | 17 | 0.550 |
Why?
| | Meningeal Neoplasms | 1 | 2018 | 88 | 0.550 |
Why?
| | Axis, Cervical Vertebra | 2 | 2022 | 9 | 0.550 |
Why?
| | Intracranial Hemorrhages | 2 | 2020 | 77 | 0.530 |
Why?
| | Skull | 1 | 2017 | 129 | 0.520 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 18 | 0.500 |
Why?
| | Ketorolac | 1 | 2015 | 18 | 0.500 |
Why?
| | EGF Family of Proteins | 1 | 2015 | 17 | 0.490 |
Why?
| | Receptor, EphA2 | 1 | 2015 | 19 | 0.490 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2015 | 22 | 0.490 |
Why?
| | Pediatrics | 2 | 2020 | 1061 | 0.490 |
Why?
| | ErbB Receptors | 2 | 2016 | 602 | 0.480 |
Why?
| | Receptor, ErbB-3 | 1 | 2015 | 45 | 0.480 |
Why?
| | Temporal Lobe | 1 | 2015 | 84 | 0.480 |
Why?
| | Brain Injuries, Traumatic | 2 | 2019 | 332 | 0.480 |
Why?
| | Choroid Plexus Neoplasms | 1 | 2014 | 9 | 0.470 |
Why?
| | src-Family Kinases | 1 | 2015 | 94 | 0.460 |
Why?
| | Perioperative Care | 1 | 2015 | 150 | 0.450 |
Why?
| | Reoperation | 5 | 2023 | 556 | 0.440 |
Why?
| | Spinal Cord Injuries | 3 | 2024 | 190 | 0.440 |
Why?
| | Data Collection | 2 | 2014 | 652 | 0.430 |
Why?
| | Professional Practice | 1 | 2014 | 65 | 0.430 |
Why?
| | Delayed Diagnosis | 2 | 2024 | 81 | 0.430 |
Why?
| | Young Adult | 17 | 2021 | 12310 | 0.420 |
Why?
| | Scoliosis | 3 | 2024 | 205 | 0.410 |
Why?
| | Moyamoya Disease | 2 | 2014 | 18 | 0.410 |
Why?
| | Quality of Life | 5 | 2023 | 2711 | 0.410 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 339 | 0.400 |
Why?
| | Neurology | 1 | 2014 | 103 | 0.400 |
Why?
| | Drug Delivery Systems | 1 | 2015 | 328 | 0.390 |
Why?
| | Artificial Intelligence | 2 | 2025 | 233 | 0.390 |
Why?
| | Decision Support Systems, Clinical | 2 | 2025 | 201 | 0.380 |
Why?
| | Urethral Diseases | 1 | 2011 | 19 | 0.380 |
Why?
| | Foreign-Body Migration | 1 | 2011 | 35 | 0.380 |
Why?
| | Genomics | 1 | 2016 | 716 | 0.380 |
Why?
| | Brain Injuries | 1 | 2016 | 468 | 0.370 |
Why?
| | Intracranial Hypertension | 2 | 2010 | 38 | 0.360 |
Why?
| | Cranial Sutures | 1 | 2010 | 11 | 0.350 |
Why?
| | Craniotomy | 2 | 2008 | 69 | 0.350 |
Why?
| | Cephalometry | 1 | 2010 | 32 | 0.350 |
Why?
| | Odontoid Process | 1 | 2010 | 5 | 0.350 |
Why?
| | Esthetics | 1 | 2010 | 50 | 0.340 |
Why?
| | Craniosynostoses | 1 | 2010 | 34 | 0.340 |
Why?
| | Biomarkers, Tumor | 3 | 2024 | 1174 | 0.340 |
Why?
| | Internal Fixators | 1 | 2010 | 38 | 0.330 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2024 | 1318 | 0.330 |
Why?
| | Societies, Medical | 1 | 2014 | 760 | 0.330 |
Why?
| | Spinal Diseases | 1 | 2010 | 48 | 0.330 |
Why?
| | Brain Stem | 1 | 2010 | 96 | 0.330 |
Why?
| | Surgeons | 1 | 2014 | 279 | 0.330 |
Why?
| | Urinary Bladder | 1 | 2011 | 175 | 0.330 |
Why?
| | MAP Kinase Signaling System | 2 | 2024 | 305 | 0.330 |
Why?
| | Patient Discharge | 1 | 2016 | 858 | 0.320 |
Why?
| | Cerebral Ventricles | 1 | 2009 | 48 | 0.320 |
Why?
| | RNA, Messenger | 2 | 2017 | 2702 | 0.310 |
Why?
| | Anemia, Sickle Cell | 2 | 2014 | 273 | 0.310 |
Why?
| | Glomus Tumor | 1 | 2008 | 2 | 0.300 |
Why?
| | Chromosomes, Human, Pair 1 | 2 | 2019 | 72 | 0.300 |
Why?
| | Brain | 5 | 2023 | 2604 | 0.300 |
Why?
| | Neuroimaging | 3 | 2020 | 275 | 0.300 |
Why?
| | Orbital Neoplasms | 1 | 2008 | 20 | 0.300 |
Why?
| | Insurance, Liability | 1 | 2008 | 6 | 0.300 |
Why?
| | Follow-Up Studies | 9 | 2024 | 4927 | 0.300 |
Why?
| | Cerebral Revascularization | 1 | 2008 | 18 | 0.290 |
Why?
| | Surgical Wound Infection | 3 | 2022 | 291 | 0.290 |
Why?
| | B7-H1 Antigen | 2 | 2020 | 175 | 0.280 |
Why?
| | Proto-Oncogene Proteins B-raf | 3 | 2019 | 211 | 0.280 |
Why?
| | Adult | 19 | 2021 | 35423 | 0.280 |
Why?
| | Medically Underserved Area | 1 | 2008 | 82 | 0.280 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2020 | 225 | 0.270 |
Why?
| | Granuloma | 2 | 2017 | 88 | 0.270 |
Why?
| | Surgical Flaps | 1 | 2008 | 143 | 0.260 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 731 | 0.260 |
Why?
| | Clinical Decision-Making | 2 | 2019 | 311 | 0.260 |
Why?
| | Autophagy | 2 | 2019 | 265 | 0.250 |
Why?
| | Prognosis | 7 | 2019 | 3793 | 0.250 |
Why?
| | Subdural Effusion | 1 | 2024 | 4 | 0.240 |
Why?
| | Neocortex | 1 | 2025 | 32 | 0.240 |
Why?
| | Pyramidal Cells | 1 | 2025 | 70 | 0.230 |
Why?
| | Computational Biology | 3 | 2025 | 588 | 0.230 |
Why?
| | Radiation Injuries | 2 | 2018 | 139 | 0.230 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2025 | 108 | 0.230 |
Why?
| | Adrenoleukodystrophy | 1 | 2024 | 8 | 0.230 |
Why?
| | Neuronavigation | 1 | 2024 | 7 | 0.220 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2024 | 22 | 0.220 |
Why?
| | Clonal Evolution | 1 | 2024 | 36 | 0.220 |
Why?
| | Drainage | 1 | 2024 | 162 | 0.220 |
Why?
| | United States | 7 | 2020 | 13992 | 0.220 |
Why?
| | Attitude of Health Personnel | 1 | 2011 | 1090 | 0.220 |
Why?
| | Microarray Analysis | 4 | 2017 | 122 | 0.220 |
Why?
| | Tumor Burden | 1 | 2024 | 284 | 0.210 |
Why?
| | Cohort Studies | 8 | 2024 | 5400 | 0.210 |
Why?
| | Astrocytoma | 1 | 2024 | 120 | 0.210 |
Why?
| | Combined Modality Therapy | 3 | 2019 | 1213 | 0.210 |
Why?
| | Brain Concussion | 2 | 2022 | 543 | 0.210 |
Why?
| | Germinoma | 1 | 2022 | 13 | 0.200 |
Why?
| | Pineal Gland | 1 | 2022 | 17 | 0.200 |
Why?
| | Pinealoma | 1 | 2022 | 11 | 0.200 |
Why?
| | Cysts | 1 | 2023 | 108 | 0.200 |
Why?
| | Software | 2 | 2025 | 612 | 0.200 |
Why?
| | Developing Countries | 1 | 2024 | 278 | 0.200 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 9 | 0.200 |
Why?
| | Hedgehog Proteins | 2 | 2022 | 187 | 0.200 |
Why?
| | Hypothalamic Diseases | 1 | 2022 | 18 | 0.190 |
Why?
| | beta Catenin | 2 | 2024 | 221 | 0.190 |
Why?
| | Endoscopy | 2 | 2015 | 268 | 0.190 |
Why?
| | Spine | 1 | 2023 | 155 | 0.190 |
Why?
| | Tumor Microenvironment | 3 | 2023 | 596 | 0.190 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2021 | 195 | 0.190 |
Why?
| | Radiation | 1 | 2021 | 25 | 0.190 |
Why?
| | Chromosome Aberrations | 2 | 2023 | 148 | 0.190 |
Why?
| | Traction | 1 | 2021 | 19 | 0.180 |
Why?
| | Neurosurgeons | 2 | 2019 | 18 | 0.180 |
Why?
| | Epilepsy | 1 | 2025 | 315 | 0.180 |
Why?
| | Cranial Fossa, Posterior | 1 | 2020 | 16 | 0.180 |
Why?
| | Kaplan-Meier Estimate | 4 | 2020 | 861 | 0.180 |
Why?
| | Disease Progression | 3 | 2024 | 2607 | 0.180 |
Why?
| | Delphi Technique | 4 | 2025 | 220 | 0.180 |
Why?
| | Equipment Failure | 1 | 2020 | 112 | 0.170 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2024 | 510 | 0.170 |
Why?
| | Preoperative Period | 1 | 2020 | 112 | 0.170 |
Why?
| | Cerebellar Neoplasms | 1 | 2022 | 150 | 0.170 |
Why?
| | Databases, Factual | 2 | 2016 | 1289 | 0.170 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 67 | 0.170 |
Why?
| | Neoplasms, Neuroepithelial | 1 | 2019 | 17 | 0.170 |
Why?
| | Middle Aged | 12 | 2020 | 31024 | 0.170 |
Why?
| | Medulloblastoma | 1 | 2022 | 192 | 0.160 |
Why?
| | Benchmarking | 1 | 2021 | 174 | 0.160 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2019 | 6 | 0.160 |
Why?
| | Sports | 1 | 2022 | 226 | 0.160 |
Why?
| | Gene Expression Profiling | 4 | 2020 | 1696 | 0.160 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2019 | 33 | 0.160 |
Why?
| | Spinal Cord Diseases | 1 | 2019 | 40 | 0.160 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 12 | 0.160 |
Why?
| | Optic Chiasm | 1 | 2019 | 19 | 0.160 |
Why?
| | Intracranial Pressure | 1 | 2019 | 46 | 0.160 |
Why?
| | Hematoma, Subdural | 1 | 2018 | 17 | 0.160 |
Why?
| | Neoplasm Grading | 2 | 2021 | 278 | 0.160 |
Why?
| | Meningomyelocele | 1 | 2019 | 59 | 0.150 |
Why?
| | Cerebellum | 1 | 2020 | 216 | 0.150 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1504 | 0.150 |
Why?
| | Decompressive Craniectomy | 1 | 2018 | 6 | 0.150 |
Why?
| | Craniospinal Irradiation | 1 | 2018 | 5 | 0.150 |
Why?
| | Spinal Curvatures | 1 | 2018 | 3 | 0.150 |
Why?
| | Cell Line, Tumor | 4 | 2019 | 3114 | 0.150 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 207 | 0.150 |
Why?
| | Specialties, Surgical | 1 | 2019 | 77 | 0.150 |
Why?
| | Phenotype | 2 | 2024 | 3062 | 0.150 |
Why?
| | Stromal Cells | 1 | 2018 | 104 | 0.150 |
Why?
| | Risk Factors | 7 | 2022 | 9804 | 0.150 |
Why?
| | Skull Neoplasms | 1 | 2017 | 23 | 0.150 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 267 | 0.150 |
Why?
| | Bone Transplantation | 1 | 2018 | 105 | 0.140 |
Why?
| | Bone Resorption | 1 | 2018 | 77 | 0.140 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 195 | 0.140 |
Why?
| | Cyst Fluid | 1 | 2017 | 27 | 0.140 |
Why?
| | Hypophysitis | 1 | 2017 | 3 | 0.140 |
Why?
| | Aged, 80 and over | 4 | 2018 | 7063 | 0.140 |
Why?
| | Patient Admission | 1 | 2018 | 185 | 0.140 |
Why?
| | Re-Irradiation | 1 | 2016 | 8 | 0.140 |
Why?
| | Chloroquine | 1 | 2017 | 52 | 0.140 |
Why?
| | Survival Analysis | 2 | 2023 | 1283 | 0.130 |
Why?
| | Blood Transfusion | 1 | 2019 | 294 | 0.130 |
Why?
| | Nurses | 1 | 2019 | 163 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2020 | 550 | 0.130 |
Why?
| | Aged | 7 | 2019 | 22068 | 0.130 |
Why?
| | Glioblastoma | 2 | 2010 | 313 | 0.130 |
Why?
| | Sarcoma, Ewing | 1 | 2017 | 86 | 0.130 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 2043 | 0.130 |
Why?
| | Algorithms | 2 | 2022 | 1626 | 0.130 |
Why?
| | Observer Variation | 1 | 2017 | 322 | 0.130 |
Why?
| | Organ Size | 1 | 2017 | 446 | 0.130 |
Why?
| | Age Factors | 3 | 2020 | 3137 | 0.130 |
Why?
| | Accidents, Traffic | 2 | 2014 | 188 | 0.130 |
Why?
| | Athletic Injuries | 1 | 2022 | 517 | 0.130 |
Why?
| | Cetirizine | 1 | 2015 | 2 | 0.120 |
Why?
| | Ambrosia | 1 | 2015 | 7 | 0.120 |
Why?
| | Nasal Sprays | 1 | 2015 | 3 | 0.120 |
Why?
| | Consensus | 3 | 2025 | 646 | 0.120 |
Why?
| | Amphiregulin | 1 | 2015 | 25 | 0.120 |
Why?
| | Cataract | 1 | 2018 | 197 | 0.120 |
Why?
| | Fluticasone | 1 | 2015 | 90 | 0.120 |
Why?
| | Rhinitis, Allergic, Seasonal | 1 | 2015 | 33 | 0.120 |
Why?
| | Length of Stay | 2 | 2019 | 1128 | 0.120 |
Why?
| | Cytokines | 3 | 2018 | 1997 | 0.120 |
Why?
| | Radiography | 4 | 2023 | 864 | 0.110 |
Why?
| | Indoles | 1 | 2017 | 378 | 0.110 |
Why?
| | Cerebral Veins | 1 | 2014 | 16 | 0.110 |
Why?
| | Logistic Models | 3 | 2019 | 1966 | 0.110 |
Why?
| | Chromosomes | 2 | 2024 | 100 | 0.110 |
Why?
| | Disease-Free Survival | 1 | 2015 | 657 | 0.110 |
Why?
| | Arachnoid Cysts | 1 | 2013 | 6 | 0.100 |
Why?
| | Sulfonamides | 1 | 2017 | 494 | 0.100 |
Why?
| | Central Nervous System Cysts | 1 | 2013 | 13 | 0.100 |
Why?
| | Survival Rate | 2 | 2019 | 1886 | 0.100 |
Why?
| | Neuropsychological Tests | 2 | 2023 | 997 | 0.100 |
Why?
| | Carcinoma | 1 | 2014 | 214 | 0.100 |
Why?
| | Seasons | 1 | 2015 | 502 | 0.100 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 11 | 0.100 |
Why?
| | Imaging, Three-Dimensional | 3 | 2017 | 559 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2019 | 3999 | 0.100 |
Why?
| | Cerebral Angiography | 2 | 2014 | 111 | 0.100 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 738 | 0.100 |
Why?
| | Emergency Service, Hospital | 1 | 2023 | 1978 | 0.100 |
Why?
| | Up-Regulation | 1 | 2015 | 850 | 0.100 |
Why?
| | Ischemic Attack, Transient | 2 | 2014 | 65 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1702 | 0.100 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1221 | 0.090 |
Why?
| | Urethra | 1 | 2011 | 52 | 0.090 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2011 | 55 | 0.090 |
Why?
| | Lymphangioma, Cystic | 1 | 2011 | 4 | 0.090 |
Why?
| | Umbilicus | 1 | 2011 | 16 | 0.090 |
Why?
| | Neurologic Examination | 1 | 2011 | 113 | 0.090 |
Why?
| | Brachial Plexus | 1 | 2011 | 28 | 0.090 |
Why?
| | Teratoma | 1 | 2011 | 102 | 0.090 |
Why?
| | Rhabdoid Tumor | 1 | 2011 | 85 | 0.090 |
Why?
| | Hematoma, Epidural, Cranial | 1 | 2010 | 4 | 0.090 |
Why?
| | Radiosurgery | 1 | 2014 | 316 | 0.090 |
Why?
| | Magnetic Resonance Angiography | 2 | 2014 | 237 | 0.090 |
Why?
| | Gene Expression | 1 | 2015 | 1477 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1284 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3047 | 0.080 |
Why?
| | Mutation | 4 | 2024 | 3679 | 0.080 |
Why?
| | Skull Fracture, Depressed | 1 | 2008 | 1 | 0.080 |
Why?
| | Head Injuries, Closed | 1 | 2008 | 50 | 0.080 |
Why?
| | Pia Mater | 1 | 2008 | 5 | 0.080 |
Why?
| | Computer Simulation | 3 | 2021 | 943 | 0.080 |
Why?
| | Electronic Health Records | 1 | 2016 | 971 | 0.070 |
Why?
| | Zygoma | 1 | 2008 | 11 | 0.070 |
Why?
| | Functional Laterality | 1 | 2009 | 217 | 0.070 |
Why?
| | Mice | 5 | 2024 | 16583 | 0.070 |
Why?
| | Topography, Medical | 1 | 2008 | 12 | 0.070 |
Why?
| | Diagnosis, Differential | 2 | 2012 | 1435 | 0.070 |
Why?
| | Temporal Arteries | 1 | 2008 | 47 | 0.070 |
Why?
| | Biopsy | 1 | 2011 | 1093 | 0.070 |
Why?
| | Foreign Bodies | 1 | 2008 | 102 | 0.070 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 178 | 0.070 |
Why?
| | Prenatal Diagnosis | 1 | 2009 | 189 | 0.070 |
Why?
| | Models, Anatomic | 1 | 2008 | 94 | 0.070 |
Why?
| | Developmental Disabilities | 1 | 2010 | 254 | 0.070 |
Why?
| | Paraganglioma | 1 | 2008 | 49 | 0.070 |
Why?
| | Diagnostic Imaging | 1 | 2010 | 327 | 0.070 |
Why?
| | Population Dynamics | 1 | 2008 | 135 | 0.070 |
Why?
| | Recurrence | 1 | 2010 | 1013 | 0.070 |
Why?
| | Signal Transduction | 1 | 2020 | 4867 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2010 | 498 | 0.060 |
Why?
| | Cerebrovascular Circulation | 1 | 2008 | 223 | 0.060 |
Why?
| | Forecasting | 1 | 2008 | 363 | 0.060 |
Why?
| | Health Services Needs and Demand | 1 | 2008 | 258 | 0.060 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 527 | 0.060 |
Why?
| | Gestational Age | 1 | 2009 | 857 | 0.060 |
Why?
| | Malformations of Cortical Development | 1 | 2025 | 13 | 0.060 |
Why?
| | Cranial Fontanelles | 1 | 2024 | 4 | 0.060 |
Why?
| | Cell Survival | 2 | 2019 | 1085 | 0.060 |
Why?
| | Seizures | 1 | 2008 | 395 | 0.060 |
Why?
| | Glasgow Coma Scale | 2 | 2018 | 170 | 0.060 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2023 | 14 | 0.060 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2024 | 48 | 0.060 |
Why?
| | Drug Resistant Epilepsy | 1 | 2025 | 77 | 0.050 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2024 | 211 | 0.050 |
Why?
| | Stroke | 2 | 2014 | 1111 | 0.050 |
Why?
| | Intelligence Tests | 1 | 2023 | 59 | 0.050 |
Why?
| | Heart Atria | 1 | 2024 | 126 | 0.050 |
Why?
| | Cranial Irradiation | 1 | 2023 | 68 | 0.050 |
Why?
| | Prospective Studies | 3 | 2024 | 7070 | 0.050 |
Why?
| | Sex Factors | 1 | 2009 | 1950 | 0.050 |
Why?
| | Fluorouracil | 1 | 2024 | 198 | 0.050 |
Why?
| | Animals | 5 | 2024 | 34708 | 0.050 |
Why?
| | Patients' Rooms | 1 | 2022 | 13 | 0.050 |
Why?
| | Abdomen | 1 | 2023 | 116 | 0.050 |
Why?
| | Mass Screening | 1 | 2010 | 1129 | 0.050 |
Why?
| | Narcotics | 1 | 2022 | 47 | 0.050 |
Why?
| | Action Potentials | 1 | 2025 | 464 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 67 | 0.050 |
Why?
| | Gene Ontology | 1 | 2021 | 49 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 288 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2023 | 190 | 0.050 |
Why?
| | Vancomycin | 1 | 2022 | 79 | 0.050 |
Why?
| | Slit Ventricle Syndrome | 1 | 2020 | 1 | 0.050 |
Why?
| | Postoperative Care | 1 | 2022 | 246 | 0.040 |
Why?
| | Transplants | 1 | 2021 | 38 | 0.040 |
Why?
| | Cell Proliferation | 2 | 2019 | 2344 | 0.040 |
Why?
| | Models, Biological | 1 | 2008 | 1704 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2021 | 190 | 0.040 |
Why?
| | DNA Copy Number Variations | 1 | 2021 | 172 | 0.040 |
Why?
| | Survivors | 1 | 2023 | 458 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2021 | 214 | 0.040 |
Why?
| | Recovery of Function | 1 | 2024 | 642 | 0.040 |
Why?
| | Genes, APC | 1 | 2019 | 13 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 340 | 0.040 |
Why?
| | Aminopyridines | 1 | 2019 | 96 | 0.040 |
Why?
| | Critical Care Nursing | 1 | 2019 | 34 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2019 | 83 | 0.040 |
Why?
| | Blood Loss, Surgical | 1 | 2019 | 91 | 0.040 |
Why?
| | Benzamides | 1 | 2019 | 192 | 0.040 |
Why?
| | Athletes | 1 | 2022 | 407 | 0.040 |
Why?
| | Surgical Wound | 1 | 2018 | 20 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 140 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2670 | 0.040 |
Why?
| | Point Mutation | 1 | 2019 | 226 | 0.040 |
Why?
| | Electronic Mail | 1 | 2018 | 61 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2013 | 1697 | 0.040 |
Why?
| | Odontogenesis | 1 | 2018 | 11 | 0.040 |
Why?
| | Laser Capture Microdissection | 1 | 2018 | 23 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 504 | 0.040 |
Why?
| | Standard of Care | 1 | 2018 | 70 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 70 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 579 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2019 | 929 | 0.040 |
Why?
| | Drug Approval | 1 | 2018 | 88 | 0.040 |
Why?
| | Receptors, HIV | 1 | 2017 | 26 | 0.040 |
Why?
| | Mucin-1 | 1 | 2017 | 20 | 0.040 |
Why?
| | Receptors, Interleukin-6 | 1 | 2017 | 36 | 0.040 |
Why?
| | Cytogenetic Analysis | 1 | 2017 | 34 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2018 | 392 | 0.040 |
Why?
| | Canada | 1 | 2018 | 355 | 0.040 |
Why?
| | DNA-Binding Proteins | 2 | 2017 | 1424 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 51 | 0.040 |
Why?
| | Pituitary Gland | 1 | 2018 | 148 | 0.040 |
Why?
| | Overweight | 1 | 2022 | 524 | 0.030 |
Why?
| | Heart-Assist Devices | 1 | 2003 | 529 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 2019 | 265 | 0.030 |
Why?
| | Prevalence | 2 | 2016 | 2541 | 0.030 |
Why?
| | Treatment Failure | 1 | 2018 | 347 | 0.030 |
Why?
| | Ki-67 Antigen | 1 | 2017 | 109 | 0.030 |
Why?
| | Brain Diseases | 1 | 2018 | 133 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2003 | 713 | 0.030 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2017 | 93 | 0.030 |
Why?
| | Neuroglia | 1 | 2018 | 166 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 799 | 0.030 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2018 | 190 | 0.030 |
Why?
| | Blotting, Western | 1 | 2019 | 1189 | 0.030 |
Why?
| | Transcription Factors | 2 | 2017 | 1636 | 0.030 |
Why?
| | Health Surveys | 1 | 2018 | 486 | 0.030 |
Why?
| | Pregnancy | 1 | 2009 | 6256 | 0.030 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 283 | 0.030 |
Why?
| | DNA Methylation | 1 | 2021 | 602 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2019 | 697 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 308 | 0.030 |
Why?
| | Drug Synergism | 1 | 2017 | 354 | 0.030 |
Why?
| | Pyrimidines | 1 | 2019 | 444 | 0.030 |
Why?
| | Pandemics | 1 | 2024 | 1516 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 422 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1147 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 1968 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1842 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 218 | 0.030 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2016 | 253 | 0.030 |
Why?
| | Quality Improvement | 1 | 2022 | 1103 | 0.030 |
Why?
| | Illinois | 1 | 2013 | 39 | 0.030 |
Why?
| | Chicago | 1 | 2013 | 51 | 0.030 |
Why?
| | Body Mass Index | 1 | 2022 | 2250 | 0.030 |
Why?
| | Registries | 1 | 2020 | 1916 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2017 | 644 | 0.030 |
Why?
| | Qualitative Research | 1 | 2019 | 1192 | 0.020 |
Why?
| | Necrosis | 1 | 2013 | 235 | 0.020 |
Why?
| | SMARCB1 Protein | 1 | 2011 | 17 | 0.020 |
Why?
| | History, 19th Century | 1 | 2011 | 56 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3336 | 0.020 |
Why?
| | Germany | 1 | 2011 | 99 | 0.020 |
Why?
| | Incidence | 1 | 2018 | 2635 | 0.020 |
Why?
| | Clinical Competence | 1 | 2018 | 1021 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2011 | 111 | 0.020 |
Why?
| | Arthritis, Juvenile | 1 | 2011 | 54 | 0.020 |
Why?
| | Apoptosis | 1 | 2019 | 2485 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2018 | 1526 | 0.020 |
Why?
| | Abducens Nerve Diseases | 1 | 2010 | 12 | 0.020 |
Why?
| | Brain Ischemia | 1 | 2014 | 308 | 0.020 |
Why?
| | History, 20th Century | 1 | 2011 | 295 | 0.020 |
Why?
| | Joint Dislocations | 1 | 2010 | 64 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2011 | 387 | 0.020 |
Why?
| | Clothing | 1 | 2008 | 20 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2847 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2009 | 425 | 0.020 |
Why?
| | Inflammation | 1 | 2018 | 2696 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5036 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2009 | 236 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2071 | 0.020 |
Why?
| | New York | 1 | 2003 | 127 | 0.010 |
Why?
| | Shock, Cardiogenic | 1 | 2003 | 61 | 0.010 |
Why?
| | Emergency Treatment | 1 | 2003 | 116 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3290 | 0.010 |
Why?
| | Stroke Volume | 1 | 2003 | 587 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2003 | 853 | 0.010 |
Why?
| | Intensive Care Units | 1 | 2003 | 733 | 0.010 |
Why?
| | Heart Ventricles | 1 | 2003 | 778 | 0.010 |
Why?
| | Time Factors | 1 | 2003 | 6579 | 0.010 |
Why?
| | Heart Failure | 1 | 2003 | 2142 | 0.010 |
Why?
|
|
Hankinson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|